antibody drug conjugate market

Global Antibody Drug Conjugate Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

  • Published Date: 2020-12-28
  • Report ID: 35104
  • Pages: 129
  • Format: prudent report format

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

Prudent Market's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global Antibody Drug Conjugate market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Antibody Drug Conjugate Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Antibody Drug Conjugate Market
Bayer AG
Concortis Biotherapeutics
F. Hoffman-La Roche Ltd.
Immunomedics, Inc.
Oxford BioTherapeutics
Pfizer Inc.
Seattle Genetics, Inc.
Takeda Pharmaceutical Company Limited
Abbvie Inc.
Astellas Pharma/Agensys
Oxford BioTherapeutics
Agensys, Inc.
Antikor
Celldex Therapeutics
Genentech
Heidelberg Pharma
Immunomedics
Mersana Therapeutics
Millennium Pharmaceuticals
Progenics Pharmaceuticals
Roche Holding Ag
Synthon
...
Major Type of Antibody Drug Conjugate Covered in Prudent Markets report:
Monoclonal Antibodies
Linker
Drug/Toxin
Others
Application Segments Covered in Prudent Markets Market
Blood Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Brain Tumor
Others

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

Global Antibody Drug Conjugate Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Monoclonal Antibodies -Product Introduction and Major Manufacturers
1.1.2 Linker -Product Introduction and Major Manufacturers
1.1.3 Drug/Toxin -Product Introduction and Major Manufacturers
1.1.4 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Antibody Drug Conjugate Status and Prospect (2015-2026)
2.1.1 China Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.1.2 China Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Antibody Drug Conjugate Status and Prospect (2015-2026)
2.2.1 EU Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.2.2 EU Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Antibody Drug Conjugate Status and Prospect (2015-2026)
2.3.1 USA Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.3.2 USA Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Antibody Drug Conjugate Status and Prospect (2015-2026)
2.4.1 Japan Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.4.2 Japan Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Antibody Drug Conjugate Status and Prospect (2015-2026)
2.5.1 India Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.5.2 India Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Antibody Drug Conjugate Status and Prospect (2015-2026)
2.6.1 Southeast Asia Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Antibody Drug Conjugate Status and Prospect (2015-2026)
2.7.1 South America Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.7.2 South America Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Antibody Drug Conjugate Status and Prospect (2015-2026)
2.8.1 Antibody Drug Conjugate Market Size and Growth Rate (2015-2026)
2.8.2 Antibody Drug Conjugate Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Antibody Drug Conjugate Market Assessment by Segment
3.1 Global Antibody Drug Conjugate Capacity and Growth Rate
3.2 Global Antibody Drug Conjugate Sales by Type
3.3 Global Antibody Drug Conjugate Sales Revenue by Type
3.4 Global Antibody Drug Conjugate Consumption by Application
4 Global Antibody Drug Conjugate Market Assessment by Regions
4.1 Global Antibody Drug Conjugate Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Antibody Drug Conjugate Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Antibody Drug Conjugate Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Antibody Drug Conjugate Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Antibody Drug Conjugate Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Antibody Drug Conjugate Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Antibody Drug Conjugate Sales Market Share of Manufacturers (2019-2020)
6.3 Global Antibody Drug Conjugate Sales Revenue Market Share of Manufacturers (2019-2020)

7 Antibody Drug Conjugate Competitive Analysis
7.1 Bayer AG
7.1.1 Bayer AG Company Profiles
7.1.2 Bayer AG Product Introduction
7.1.3 Bayer AG Antibody Drug Conjugate Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Concortis Biotherapeutics
7.2.1 Concortis Biotherapeutics Company Profiles
7.2.2 Concortis Biotherapeutics Product Introduction
7.2.3 Concortis Biotherapeutics Antibody Drug Conjugate Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 F. Hoffman-La Roche Ltd.
7.3.1 F. Hoffman-La Roche Ltd. Company Profiles
7.3.2 F. Hoffman-La Roche Ltd. Product Introduction
7.3.3 F. Hoffman-La Roche Ltd. Antibody Drug Conjugate Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Immunomedics, Inc.
7.4.1 Immunomedics, Inc. Company Profiles
7.4.2 Immunomedics, Inc. Product Introduction
7.4.3 Immunomedics, Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Oxford BioTherapeutics
7.5.1 Oxford BioTherapeutics Company Profiles
7.5.2 Oxford BioTherapeutics Product Introduction
7.5.3 Oxford BioTherapeutics Antibody Drug Conjugate Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Profiles
7.6.2 Pfizer Inc. Product Introduction
7.6.3 Pfizer Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Seattle Genetics, Inc.
7.7.1 Seattle Genetics, Inc. Company Profiles
7.7.2 Seattle Genetics, Inc. Product Introduction
7.7.3 Seattle Genetics, Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Takeda Pharmaceutical Company Limited Company Profiles
7.8.2 Takeda Pharmaceutical Company Limited Product Introduction
7.8.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Abbvie Inc.
7.9.1 Abbvie Inc. Company Profiles
7.9.2 Abbvie Inc. Product Introduction
7.9.3 Abbvie Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Astellas Pharma/Agensys
7.10.1 Astellas Pharma/Agensys Company Profiles
7.10.2 Astellas Pharma/Agensys Product Introduction
7.10.3 Astellas Pharma/Agensys Antibody Drug Conjugate Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Oxford BioTherapeutics
7.12 Agensys, Inc.
7.13 Antikor
7.14 Celldex Therapeutics
7.15 Genentech
7.16 Heidelberg Pharma
7.17 Immunomedics
7.18 Mersana Therapeutics
7.19 Millennium Pharmaceuticals
7.20 Progenics Pharmaceuticals
7.21 Roche Holding Ag
7.22 Synthon
8 Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.